abrdn Australia Equity Fund Commentary For The Quarter Ended January 31, 2025

2025-03-28 06:25:00 ET

Summary

• The Fund outperformed the ASX 200 Index, returning 0.94% due to strong stock selection, particularly in healthcare and consumer discretionary sectors.
• Key performers included Pro Medicus, ResMed, Aristocrat Leisure, ALS, and Hub24, while Northern Star Resources and Mirvac underperformed.
• New investments were made in Viva Energy, Capstone Copper Corporation, and Seven Group, while exiting Medibank.
• The RBA cut interest rates, and the portfolio strategy focuses on quality companies with strong pricing power and clear growth prospects.

Fund performance

Read the full article on Seeking Alpha

For further details see: